Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Remotely Monitored Medical Devices: Intel Inside?

This article was originally published in The Gray Sheet

Executive Summary

Microprocessing giant Intel plans to bring its computer business savvy to the telehealth device arena as early as 2008

You may also be interested in...



GE, Intel Form Home Health Technology Alliance To Boost Sales, R&D

GE and Intel will invest $250 million over the next five years to develop home-based health technologies for seniors and chronically-ill patients, the firms announced April 2

GE, Intel Form Home Health Technology Alliance To Boost Sales, R&D

GE and Intel will invest $250 million over the next five years to develop home-based health technologies for seniors and chronically-ill patients, the firms announced April 2

Intel’s First Home-Monitor Device Clears FDA, Will Launch This Year

Computer chip giant Intel expects to get into the U.S. medical device market later this year with the Health Guide home chronic condition management tool

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT025399

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel